Difficulty: Medium
Average Score: 71%
Practice
A patient with thalassemia has been found to have high iron levels. Which of the following agents would be appropriate for management of this patient?
Correct answer
C
Rationale
The correct answer is C: Deferoxamine. Thalassemia patients often require blood transfusions, leading to iron overload. Deferoxamine is an iron-chelating agent that helps remove excess iron from the body. Ferrous sulphate (A) is an iron supplement and would worsen iron overload. Hydroxycobalamin (B) is a form of vitamin B12 and is not indicated for iron overload. Iron dextran (D) is another form of iron supplement and would also exacerbate the iron overload in this patient. Therefore, the appropriate choice is C as it directly addresses the issue of high iron levels in thalassemia patients.